205 related articles for article (PubMed ID: 10604965)
1. Pharmacological examination of the neurokinin-1 receptor mediating relaxation of human intralobar pulmonary artery.
Pedersen KE; Buckner CK; Meeker SN; Undem BJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):319-25. PubMed ID: 10604965
[TBL] [Abstract][Full Text] [Related]
2. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
3. Role of nitric oxide and septide-insensitive NK(1) receptors in bronchoconstriction induced by aerosolised neurokinin A in guinea-pigs.
Ricciardolo FL; Trevisani M; Geppetti P; Nadel JA; Amadesi S; Bertrand C
Br J Pharmacol; 2000 Mar; 129(5):915-20. PubMed ID: 10696090
[TBL] [Abstract][Full Text] [Related]
4. Neurokinins induce relaxation of human pulmonary vessels through stimulation of endothelial NK1 receptors.
Mechiche H; Koroglu A; Candenas L; Pinto FM; Birembaut P; Bardou M; Elaerts J; Devillier P
J Cardiovasc Pharmacol; 2003 Mar; 41(3):343-55. PubMed ID: 12605012
[TBL] [Abstract][Full Text] [Related]
5. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
7. Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers.
Brunelleschi S; Nicali R; Lavagno L; Viano I; Pozzi E; Gagliardi L; Ghio P; Albera C
Neuropeptides; 2000 Feb; 34(1):45-50. PubMed ID: 10688968
[TBL] [Abstract][Full Text] [Related]
8. Use of selective antagonists for further characterization of tachykinin NK-2, NK-1 and possible "septide-selective" receptors in guinea pig bronchus.
Zeng XP; Burcher E
J Pharmacol Exp Ther; 1994 Sep; 270(3):1295-300. PubMed ID: 7523658
[TBL] [Abstract][Full Text] [Related]
9. Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies.
Juszczak M; Boczek-Leszczyk E; Stempniak B
J Physiol Pharmacol; 2007 Dec; 58(4):829-43. PubMed ID: 18195491
[TBL] [Abstract][Full Text] [Related]
10. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the pressor response to tachykinins in isolated perfused rat kidney.
Chen Y; Hoover DB
J Pharmacol Exp Ther; 1993 Dec; 267(3):1176-80. PubMed ID: 7505328
[TBL] [Abstract][Full Text] [Related]
12. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
13. Tachykinin receptor subtypes in the isolated guinea pig heart and their role in mediating responses to neurokinin A.
Chang Y; Hoover DB; Hancock JC; Smith FM
J Pharmacol Exp Ther; 2000 Jul; 294(1):147-54. PubMed ID: 10871306
[TBL] [Abstract][Full Text] [Related]
14. Effects of neuropeptides on the sumatriptan-disturbed circulation in the optic nerve head of rabbits.
Gaspar MN; Ribeiro CA; Cunha-Vaz JG; Macedo TR
Pharmacology; 2004 Mar; 70(3):152-9. PubMed ID: 14752235
[TBL] [Abstract][Full Text] [Related]
15. Tachykinins (substance P, neurokinin A, neuropeptide K, and neurokinin B) in the cerebral circulation: vasomotor responses in vitro and in situ.
Jansen I; Alafaci C; McCulloch J; Uddman R; Edvinsson L
J Cereb Blood Flow Metab; 1991 Jul; 11(4):567-75. PubMed ID: 1711051
[TBL] [Abstract][Full Text] [Related]
16. Tachykinin receptors mediating contraction of guinea pig lung strips.
Killingsworth CR; Shore SA
Regul Pept; 1995 May; 57(2):149-61. PubMed ID: 7544902
[TBL] [Abstract][Full Text] [Related]
17. Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2.
Devillier P; Acker GM; Advenier C; Marsac J; Regoli D; Frossard N
J Pharmacol Exp Ther; 1992 Nov; 263(2):767-72. PubMed ID: 1279160
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
Sagan S; Chassaing G; Pradier L; Lavielle S
J Pharmacol Exp Ther; 1996 Mar; 276(3):1039-48. PubMed ID: 8786533
[TBL] [Abstract][Full Text] [Related]
20. Tachykinin NK-2 receptors in child urinary bladder.
Zeng XP; Burcher E
J Urol; 1996 Mar; 155(3):1104-7. PubMed ID: 8583573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
